Literature DB >> 21238779

High throughput tryptic digestion via poly (acrylamide-co-methylenebisacrylamide) monolith based immobilized enzyme reactor.

Shuaibin Wu1, Liangliang Sun, Junfeng Ma, Kaiguang Yang, Zhen Liang, Lihua Zhang, Yukui Zhang.   

Abstract

A poly (acrylamide-co-methylenebisacrylamide) (poly (AAm-co-MBA)) monolith was prepared by thermal polymerization in the 100 or 250 μm i.d. capillary. The monolithic support was activated by ethylenediamine followed by glutaraldehyde. Trypsin was then introduced to form an immobilized enzyme reactor (IMER). The prepared IMER showed a reliable mechanical stability and permeability (permeability constant K=2.65×10(-13) m(2)). With BSA as the model protein, efficient digestion was completed within 20s, yielding the sequence coverage of 57%, better than that obtained from the traditional in-solution digestion (42%), which took about 12h. Moreover, BSA down to femtomole was efficiently digested by the IMER and positively identified by matrix assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS). To test the applicability of IMER for complex sample profiling, proteins extracted from Escherichia coli were digested by the IMER and further analyzed by nanoreversed phase liquid chromatography-electrospray ionization-mass spectrometry (nanoRPLC-ESI-MS/MS). In comparison to in-solution digestion, despite slightly fewer proteins were positively identified at a false discovery rate (FDR) of ∼1% (333 vs 411), the digestion time used was largely shortened (20s vs 24 h), implying superior digestion performance for the high throughput analysis of complex samples. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21238779     DOI: 10.1016/j.talanta.2010.12.011

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  1 in total

Review 1.  Immobilized enzyme reactors in HPLC and its application in inhibitor screening: A review.

Authors:  Si-Meng Fang; Hai-Na Wang; Zhong-Xi Zhao; Wei-Hong Wang
Journal:  J Pharm Anal       Date:  2011-12-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.